EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62017TO0733
Order of the President of the General Court of 23 November 2018.#GMP-Orphan (GMPO) v European Commission.#Interim relief — Medicinal products for human use — Active substance trientine tetrahydrochloride — Commission decision not to classify the medicinal product Cuprior-trientine as an orphan medicinal product — Regulation (EC) No 141/2000 — Application for suspension of operation of a measure — Lack of urgency.#Case T-733/17 R.
Order of the President of the General Court of 23 November 2018.
GMP-Orphan (GMPO) v European Commission.
Interim relief — Medicinal products for human use — Active substance trientine tetrahydrochloride — Commission decision not to classify the medicinal product Cuprior-trientine as an orphan medicinal product — Regulation (EC) No 141/2000 — Application for suspension of operation of a measure — Lack of urgency.
Case T-733/17 R.
Order of the President of the General Court of 23 November 2018.
GMP-Orphan (GMPO) v European Commission.
Interim relief — Medicinal products for human use — Active substance trientine tetrahydrochloride — Commission decision not to classify the medicinal product Cuprior-trientine as an orphan medicinal product — Regulation (EC) No 141/2000 — Application for suspension of operation of a measure — Lack of urgency.
Case T-733/17 R.
ECLI identifier: ECLI:EU:T:2018:839